Progression after First-Line Cyclin-Dependent Kinase 4/6 Inhibitor Treatment: Analysis of Molecular Mechanisms and Clinical Data

por Villa, Federica, Crippa, Alessandra, Pelizzoni, Davide, Ardizzoia, Alessandra, Scartabellati, Giulia, Corbetta, Cristina, Cipriani, Eleonora, Lavitrano, Marialuisa, Ardizzoia, Antonio
Publicado 2023

In vivo engineering of oncogenic chromosomal rearrangements with the CRISPR/Cas9 system

por Maddalo, Danilo, Manchado, Eusebio, Concepcion, Carla P., Bonetti, Ciro, Vidigal, Joana A., Han, Yoon-Chi, Ogrodowski, Paul, Crippa, Alessandra, Rekhtman, Natasha, de Stanchina, Elisa, Lowe, Scott W., Ventura, Andrea
Publicado 2014